Oncolinx oncolinx.com


Public list: Pharma Startups (4734) Cancer Therapeutics (1145)

Oncolinx is developing antibody-drug conjugates, which carry an Azonafide cytotoxin attached to an antibody specifically to tumor cells and not healthy cells, thereby avoiding many of the side effects associated with traditional forms of chemotherapy.

Oncolinx is developing antibody-drug conjugates, which carry an Azonafide cytotoxin attached to an antibody specifically to tumor cells and not healthy cells, thereby avoiding many of the side effects associated with traditional forms of chemotherapy...Show all

Company (Alive / Active)

All investors data 3 Investors

Phone: 848-391-9367

Fax:

745 Atlantic Avenue

 Boston, 02111
 Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Oncolinx $1.4M Oct 28, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Oncolinx Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)